Invivyd to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Invivyd (Nasdaq: IVVD), a biopharmaceutical company focused on protection from serious viral infectious diseases, has announced its participation in three upcoming investor conferences in New York, NY:

• Morgan Stanley 22nd Annual Global Healthcare Conference on September 6, 2024, at 10:00 AM ET
• H.C. Wainwright 26th Annual Global Investment Conference on September 9, 2024, at 9:30 AM ET
• 2024 Cantor Global Healthcare Conference on September 18, 2024, at 10:55 AM ET

Live webcasts of the fireside chats will be available on Invivyd's investor website and archived for approximately 90 days after the events.

WALTHAM, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it will present at the following investor conferences:

Morgan Stanley 22nd Annual Global Healthcare Conference
Fireside Chat Date: Friday, September 6, 2024
Fireside Chat Time: 10:00 AM ET
Location: New York, NY

H.C. Wainwright 26th Annual Global Investment Conference
Fireside Chat Date: Monday, September 9, 2024
Fireside Chat Time: 9:30 AM ET
Location: New York, NY

2024 Cantor Global Healthcare Conference
Fireside Chat Date: Wednesday, September 18, 2024
Fireside Chat Time: 10:55 AM ET
Location: New York, NY

Live webcasts of the fireside chats will be available in the investor section of the company’s website at investors.invivyd.com and will be archived for approximately 90 days following the events.

About Invivyd
Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. The company’s proprietary INVYMAB™ platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to address evolving viral threats. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for its first mAb in a planned series of innovative antibody candidates. Visit https://invivyd.com/ to learn more.

Contacts:

Media Relations
(781) 208-0160
media@invivyd.com

Investor Relations
(781) 208-0160
investors@invivyd.com

FAQ

What investor conferences is Invivyd (IVVD) attending in September 2024?

Invivyd is participating in three investor conferences in September 2024: Morgan Stanley Global Healthcare Conference on September 6, H.C. Wainwright Global Investment Conference on September 9, and Cantor Global Healthcare Conference on September 18.

Where can I watch the webcasts of Invivyd's (IVVD) investor conference presentations?

Live webcasts of Invivyd's fireside chats at the investor conferences will be available in the investor section of the company's website at investors.invivyd.com. They will be archived for approximately 90 days following the events.

What is the date and time of Invivyd's (IVVD) presentation at the Morgan Stanley Global Healthcare Conference?

Invivyd will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Friday, September 6, 2024, at 10:00 AM ET in New York, NY.

When is Invivyd (IVVD) presenting at the 2024 Cantor Global Healthcare Conference?

Invivyd will have a fireside chat at the 2024 Cantor Global Healthcare Conference on Wednesday, September 18, 2024, at 10:55 AM ET in New York, NY.